SomnoMed Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 8 million compared to AUD 4.44 million a year ago. Basic loss per share from continuing operations was AUD 0.1001 compared to AUD 0.0563 a year ago.

Diluted loss per share from continuing operations was AUD 0.1001 compared to AUD 0.0563 a year ago. Basic loss per share was AUD 0.1018 compared to AUD 0.0565 a year ago. Diluted loss per share was AUD 0.1018 compared to AUD 0.0565 a year ago.